Reviewed by Dr. Elena Vance, DOLast reviewed 4 sources cited
Quick Summary
Bydureon BCise (exenatide) and Mounjaro (tirzepatide) are both incretin-based therapies. In clinical trials, Mounjaro showed greater weight loss (22.5% vs 2.3%).
See the comparison table below for detailed side-by-side data.
Bydureon BCise vs Mounjaro: Full Comparison
| Feature | Bydureon BCise(exenatide extended-release) | Mounjaro(tirzepatide) |
|---|---|---|
| Active Ingredient | exenatide | tirzepatide |
| Drug Class | GLP-1 receptor agonist | Dual GIP and GLP-1 receptor agonist |
| Manufacturer | AstraZeneca | Eli Lilly |
| FDA Approved | 2012-01-27 | 2022-05-13 |
| Approved Indications |
|
|
| Route | subcutaneous injection | subcutaneous injection |
| Frequency | Once weekly | Once weekly |
| Starting Dose | 2 mg weekly | 2.5 mg weekly |
| Maintenance Dose | 2 mg weekly | 5 mg, 10 mg, or 15 mg weekly |
| Max Dose | 2 mg weekly | 15 mg weekly |
| Weight Loss (%) | 2.3% | 22.5% |
| A1C Reduction | 1.3% | 2.4% |
| Key Trial | DURATION-1 (30 weeks) | SURMOUNT-1 (72 weeks) |
| List Price | $800-$950/month | $1,023-$1,176/month |
| With Insurance | $25-$100/month (varies by plan) | $25-$150/month (varies by plan) |
| Savings Card | Limited savings programs available | $25/month (Lilly savings card, commercially insured) |
Side Effects: Bydureon BCise vs Mounjaro
| Side Effect | Bydureon BCise | Mounjaro |
|---|---|---|
| Nausea | 11% | 12-18% |
| Diarrhea | 9% | 12-17% |
| Injection site nodule | 10-17% | Not reported |
| Headache | 8% | Not reported |
| Vomiting | 4% | 5-9% |
| Constipation | 6% | 6-7% |
| Pancreatitis (rare) | <1% | <0.5% |
| Decreased appetite | Not reported | 5-11% |
| Dyspepsia | Not reported | 5-8% |
| Abdominal pain | Not reported | 5-6% |
| Injection site reaction | Not reported | 3-5% |
Severity scale: 1 (mild) to 5 (serious). Based on FDA prescribing information and clinical trial data.
Related Comparisons
Frequently Asked Questions
Sources & References
This content is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions. See our full medical disclaimer.